» Articles » PMID: 36330010

Mid-term Subclinical Myocardial Injury Detection in Patients Who Recovered from COVID-19 According to Pulmonary Lesion Severity

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) may cause damage to the cardiovascular system during the acute phase of the infection. However, recent studies reported mid- to long-term subtle cardiac injuries after recovering from acute coronavirus disease 2019 (COVID-19). This study aimed to determine the relationship between the severity of chest computed tomography (CT) lesions and the persistence of subtle myocardial injuries at mid-term follow-up of patients who recovered from COVID-19 infection.

Methods: All patients with COVID-19 were enrolled prospectively in this study. Sensitive troponin T (hsTnT) and chest CT scans were performed on all patients during the acute phase of COVID-19 infection. At the mid-term follow-up, conventional transthoracic echocardiograph and global longitudinal strain (GLS) of the left and right ventricles (LV and RV) were determined and compared between patients with chest CT scan lesions of < 50% (Group 1) and those with severe chest CT scan lesions of greater or equal to 50% (Group 2).

Results: The mean age was 55 ± 14 years. Both LV GLS and RV GLS values were significantly decreased in group 2 ( = 0.013 and = 0.011, respectively). LV GLS value of more than -18 was noted in 43% of all the patients, and an RV GLS value of more than -20 was observed in 48% of them. The group with severe chest CT scan lesions included more patients with reduced LV GLS and reduced RV GLS than the group with mild chest CT scan lesions [(G1:29 vs. G2:57%, = 0.002) and (G1:36 vs. G2:60 %, = 0.009), respectively].

Conclusion: Patients with severe chest CT scan lesions are more likely to develop subclinical myocardial damage. Transthoracic echocardiography (TTE) could be recommended in patients recovering from COVID-19 to detect subtle LV and RV lesions.

Citing Articles

A deeper look at long-term effects of COVID-19 on myocardial function in survivors with no prior heart diseases: a GRADE approach systematic review and meta-analysis.

Dehghan M, Mirzohreh S, Kaviani R, Yousefi S, Pourmehran Y Front Cardiovasc Med. 2024; 11:1458389.

PMID: 39628552 PMC: 11611865. DOI: 10.3389/fcvm.2024.1458389.


Use of strain imaging to detect subtle myocardial involvement in post COVID-19 patients: An Indian perspective.

Tomar D, Kapoor A, Hashim Z, Raut K, Katheria A, Khare H Indian Heart J. 2024; 76(5):309-314.

PMID: 39362598 PMC: 11584371. DOI: 10.1016/j.ihj.2024.09.003.

References
1.
Lee S, Lee S, Rhee K, Chae J, Kim W . Usefulness of Myocardial Longitudinal Strain in Prediction of Heart Failure in Patients with Successfully Reperfused Anterior Wall ST-segment Elevation Myocardial Infarction. Korean Circ J. 2019; 49(10):960-972. PMC: 6753029. DOI: 10.4070/kcj.2018.0421. View

2.
Akhmerov A, Marban E . COVID-19 and the Heart. Circ Res. 2020; 126(10):1443-1455. DOI: 10.1161/CIRCRESAHA.120.317055. View

3.
Pellikka P, Naqvi T . The Right Ventricle: A Target in COVID-19 Cardiac Insult. J Am Coll Cardiol. 2020; 76(17):1978-1981. PMC: 7834005. DOI: 10.1016/j.jacc.2020.09.529. View

4.
Bonnemain J, Ltaief Z, Liaudet L . The Right Ventricle in COVID-19. J Clin Med. 2021; 10(12). PMC: 8230058. DOI: 10.3390/jcm10122535. View

5.
Mohebali D, Heidinger B, Feldman S, Matos J, Dabreo D, McCormick I . Right ventricular strain in patients with pulmonary embolism and syncope. J Thromb Thrombolysis. 2019; 50(1):157-164. DOI: 10.1007/s11239-019-01976-w. View